Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis
Not Applicable
- Conditions
- pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis
- Registration Number
- JPRN-UMIN000020543
- Lead Sponsor
- ational Hospital Organization Okayama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a contraindication to imatinib Patients who were considered as inadequate for enrollment by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy (Time to clinical worsening)
- Secondary Outcome Measures
Name Time Method Safety Efficacy (Median survival)